For the Inventor, By the Inventor

Enter assignee name

Quest Pharmatech, Inc.

USPTO Granted Patents = 10

% Expired Patents = 20.0

CIPO Patents = 2

EPO Patents = 3

Forward Citations = 32

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Thomas Woo (6 out of 6 patents)

Ragupathy Madiyalakan (4 out of 16 patents)

Selvaraj A Naicker (4 out of 28 patents)

4. Sanjay K Sharma (4 out of 4 patents)

5. Christopher F Nicodemus (3 out of 7 patents)

6. Birgit Corinna Schultes (3 out of 8 patents)

7. Azita Haddadi (1 out of 1 patent)

8. Manuel L Penichet (1 out of 6 patents)

9. Tracy R Daniels (1 out of 1 patent)

10. Gustavo Helguera (1 out of 2 patents)

11. Gerald George Miller (1 out of 1 patent)

12. Antoine A Noujaim (1 out of 18 patents)

13. Michael Hollingsworth (1 out of 1 patent)

14. Prakash Radhakrishnan (1 out of 1 patent)

15. Jose A Rodriguez (1 out of 2 patents)

10 patents: Sort by Forward Citations

1. 11773183 - MUC16 monoclonal antibody and uses thereof (2023-10-03),

2. 8945566 - Methods for improving the bioactivity of therapeutic IgE antibodies for the treatment of disease (2015-02-03),

3. 8916205 - Polymeric nanoparticles for photosensitizers (2014-12-23),

4. 8758725 - Perylenequinone derivatives and uses thereof (2014-06-24),

5. 8747811 - Perylenequinone derivatives and uses thereof (2014-06-10),

6. 8697079 - IgE antibodies for the treatment of cancer (2014-04-15),

7. 8506931 - Perylenequinone derivatives and uses thereof (2013-08-13),

8. 8454991 - Method and device for photodynamic therapy (2013-06-04),

9. 8038994 - Combination therapy for treating disease (2011-10-18),

10. 7659244 - Rapamycin peptides conjugates: synthesis and uses thereof (2010-02-09),

Quest Pharmatech, Inc. is a publicly traded biotechnology company focused on the development and commercialization of innovative immunotherapeutic products for the treatment of cancer. Their proprietary technologies aim to enhance the body's immune response to various types of cancers, providing more effective and targeted treatments. With a strong commitment to research and development, Quest Pharmatech is at the forefront of advancing new therapies for cancer patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

10 Patents

#135 in

#1,520 in Canada

#55,869 in the World

Quest Pharmatech, Inc.

Forward Citations = 32

15 inventors:

Thomas Woo (6 out of 6 patents)

Ragupathy Madiyalakan (4 out of 16 patents)

Selvaraj A Naicker (4 out of 28 patents)

4. Sanjay K Sharma (4 out of 4 patents)

5. Christopher F Nicodemus (3 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…